GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 395, 709–733 (2020).
Dumanski, S. M. & Ahmed, S. B. Fertility and reproductive care in chronic kidney disease. J. Nephrol. 32, 39–50 (2019).
Mills, K. T. et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 88, 950–957 (2015).
Article PubMed PubMed Central Google Scholar
Feig, D. S. Epidemiology and therapeutic strategies for women with preexisting diabetes in pregnancy: how far have we come? The 2021 Norbert Freinkel Award Lecture. Diabetes Care 45, 2484–2491 (2022).
Mackin, S. T. et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia 61, 1081–1088 (2018).
PubMed PubMed Central Google Scholar
Wang, M. C. et al. Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013 to 2018. J. Am. Heart Assoc. 10, e020717 (2021).
Article PubMed PubMed Central Google Scholar
Strauss, A. et al. Obesity in pregnant women: a 20-year analysis of the German experience. Eur. J. Clin. Nutr. 75, 1757–1763 (2021).
Article PubMed PubMed Central Google Scholar
Poston, L. et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 4, 1025–1036 (2016).
Ananth, C. V. et al. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension 74, 1089–1095 (2019).
Article CAS PubMed Google Scholar
Care of pregnant women. Boston Med. Surg. J. 166:292–293 (1912).
Jesudason, S. & Tong, A. The patient experience of kidney disease and pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 57, 77–88 (2019).
Ralston, E. R. et al. Exploring biopsychosocial correlates of pregnancy risk and pregnancy intention in women with chronic kidney disease. J. Nephrol. 36, 1361–1372 (2023).
Article PubMed PubMed Central Google Scholar
Pregnancy and renal disease. Lancet. 2:801–802 (1975).
Mc Laughlin, L. et al. Feminizing care pathways: mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. J. Adv. Nurs. 79, 3127–3146 (2023).
Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337–366 (2005).
Article CAS PubMed Google Scholar
Camaioni A., Klinger F. G., Campagnolo L., Salustri A. The influence of pentraxin 3 on the ovarian function and its impact on fertility. Front. Immunol. 9, 2808 (2018).
Article PubMed PubMed Central Google Scholar
Rojas, R., Clegg, D. J. & Palmer, B. F. Amenorrhea and estrogen disorders in kidney disease. Semin. Nephrol. 41, 126–132 (2021).
Article CAS PubMed Google Scholar
Wiles, K. et al. Anti-Müllerian hormone concentrations in women with chronic kidney disease. Clin. Kidney J. 14, 537–542 (2021).
Article CAS PubMed Google Scholar
Gupta, J. et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin. J. Am. Soc. Nephrol. 7, 1938–1946 (2012).
Article CAS PubMed PubMed Central Google Scholar
Holley, J. L., Schmidt, R. J., Bender, F. H., Dumler, F. & Schiff, M. Gynecologic and reproductive issues in women on dialysis. Am. J. Kidney Dis. 29, 685–690 (1997).
Article CAS PubMed Google Scholar
Hou, S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am. J. Kidney Dis. 33, 235–252 (1999).
Article CAS PubMed Google Scholar
Hewawasam, E. et al. Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years. Nephrol. Dial. Transpl. 37, 1152–1161 (2022).
Vrijlandt, W. A. L. et al. Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J. Nephrol. 36, 1341–1347 (2023).
Article CAS PubMed Google Scholar
Uldall, P. R., Kerr, D. N. & Tacchi, D. Sterility and cyclophosphamide. Lancet. 1, 693–694 (1972).
Article CAS PubMed Google Scholar
Gajjar, R., Miller, S. D., Meyers, K. E. & Ginsberg, J. P. Fertility preservation in patients receiving cyclophosphamide therapy for renal disease. Pediatr. Nephrol. 30, 1099–1106 (2015).
Kidney Disease: Improving Global Outcomes (KDIGO) glomerular diseases work group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1–S276 (2021).
Dines, V. A., Garovic, V. D., Parashuram, S., Cosio, F. G. & Kattah, A. G. Pregnancy, contraception, and menopause in advanced chronic kidney disease and kidney transplant. Womens Health Rep. 2, 488–496 (2021).
Rytz, C. L. et al. Menstrual abnormalities and reproductive lifespan in females with CKD: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 17, 1742–1753 (2022).
Article PubMed PubMed Central Google Scholar
Dines, V. A. & Garovic, V. D. Menopause and chronic kidney disease. Nat. Rev. Nephrol. 20, 4–5 (2023).
Vellanki, K. & Hou, S. Menopause in CKD. Am. J. Kidney Dis. 71, 710–719 (2018).
Iwase, A. et al. Anti‐Müllerian hormone as a marker of ovarian reserve: what have we learned, and what should we know? Reprod. Med. Biol. 15, 127–136 (2015).
Article PubMed PubMed Central Google Scholar
Seifer, D. B., Baker, V. L. & Leader, B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil. Steril. 95, 747–750 (2011).
Article CAS PubMed Google Scholar
Şenateş, E. et al. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J. Crohns Colitis 7, e29–e34 (2013).
Cakmak, E., Karakus, S., Demirpence, O. & Coskun, B. D. Ovarian reserve assessment in celiac patients of reproductive age. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 24, 1152–1157 (2018).
Karampatou, A. et al. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. J. Hepatol. https://doi.org/10.1016/j.jhep.2017.08.019 (2017).
Aydogan Mathyk, B., Aslan Cetin, B., Bilici, S., Fasse, J. & Avci, P. Evaluation of ovarian reserve in women with psoriasis. Gynecol. Endocrinol. 35, 608–611 (2019).
Article CAS PubMed Google Scholar
Lin, C. et al. The value of anti-Müllerian hormone in the prediction of spontaneous pregnancy: a systematic review and meta-analysis. Front. Endocrinol. 12, 695157 (2021).
Steiner, A. Z. et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 318, 1367–1376 (2017).
Article CAS PubMed PubMed Central Google Scholar
Venturella, R. et al. OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters. J. Ovarian Res. 8, 21 (2015).
Comments (0)